Corbus Pharmaceuticals Holdings, Inc.
Status: Publicly traded
Direct answer
Corbus Pharmaceuticals Holdings, Inc. is publicly traded on NASDAQ under the ticker CRBP.
Corbus Pharmaceuticals Holdings, Inc. operates as a biopharmaceutical firm, concentrating on creating immune modulators designed to combat immuno-oncology and various fibrotic conditions. Its pipeline includes lenabasum, an orally administered small molecule. This compound selectively activates cannabinoid receptor type 2 (CB2) and is currently undergoing Phase II clinical trials for the treatment of systemic lupus...
Can you invest in Corbus Pharmaceuticals Holdings, Inc.?
Yes. Corbus Pharmaceuticals Holdings, Inc. is publicly traded on NASDAQ under the ticker CRBP.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Corbus Pharmaceuticals Holdings, Inc.
Detailed equity research is provided by MarketSnap.